RxSight, Inc. (RXST) Tops Q1 EPS by 22c

RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.31), $0.22 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.28 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit